Management of cervical cancer and surgical-pathological staging (SPS). Report of our clinical case series.
FIGO staging is imprecise in a relevant number of cases of cervical cancer, especially in advanced stages, when the prognosis and the choice of the therapy are most delicate. The Authors examine their case series about the index of correction of FIGO staging after Surgical Pathological Staging (SPS). Surgical Pathological Staging was applied systematically in 788 cases and revealed errors in FIGO staging in 16% of cases at stage I; 77% at stage II; and 96% at stage III. SPS allows a more precise knowledge of neoplastic diffusion and consequently to the elimination of many false advanced stages and to adequate the treatment. Furthermore 5 year survival rate confirms the role of SPS and Surgical therapy alone or combined with Radiotherapy and Chemotherapy in every stages of diffusion of cervical cancer.
Onnis
A
A
Gynec, Institute, University of Padua, Italy.
Marchetti
M
M
Maggino
T
T
Cascio
A
A
Cerri
G
G
Dipasquale
C
C
Meneghello
E
E
Romagnolo
C
C
Rozzo
M L
ML
D005260:Female; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods*; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy